Brief: Cannara Biotech Posts Quarterly Profit of 6 Canadian Cents
25/11/2024 16:04
Nov 25 (Reuters) - Cannara Biotech Inc LOVE.V :
* CANNARA BIOTECH INC. REPORTS Q4 AND FISCAL YEAR 2024
RESULTS:
ACHIEVES RECORD SALES GROWTH AND OPERATING CASH FLOW,
SOLIDIFYING LEADERSHIP IN CANADA'S CANNABIS MARKET
* CANNARA BIOTECH INC: QTRLY EPS C$0.06
Further company coverage: LOVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04